61.72

0.49% 0.30

After Hours: 61.72

Mbx Biosciences Inc (MBX)

Overview News Price History Discussions Forecast

Mbx Biosciences Inc stock is traded at $61.72, with a volume of 271.77K. It is up +0.49% in the last 24 hours and down -12.70% over the past month. MBX Biosciences Inc is a clinical stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders. The company designed its proprietary Precision Endocrine Peptide, or PEP, platform to overcome the key limitations of unmodified and modified peptide therapies to improve clinical outcomes and simplify disease management for patients. Its PEPs are selectively engineered to have optimized pharmaceutical properties, including extended time-action profiles and consistent drug concentrations with low peak-to-trough concentration ratios, consistent exposure to target tissues, and less frequent dosing. Its product candidates include canvuparatide (MBX 2109), imapextide (MBX 1416), and MBX 4291.

Previous Close:

$61.42

Open:

$61

24h Volume:

271.77K

Relative Volume:

0.36

Market Cap:

$2.97B

Revenue:

Net Income/Loss:

$-86.97M

P/E Ratio:

-25.52

EPS:

-2.4189

Net Cash Flow:

$-81.88M

1W Performance:

-2.03%

1M Performance:

-12.70%

6M Performance:

+97.13%

1Y Performance:

+377.71%

1-Day Range:

$60.59

$62.73

1-Week Range:

$58.80

$63.04

52-Week Range:

$9.63

$72.64

Mbx Biosciences Inc Stock (MBX) Company Profile

Name

Mbx Biosciences Inc

Sector

Healthcare (1074)

Industry

Biotechnology (600)

Phone

(317) 989-3100

Address

11711 N. MERIDIAN STREET, CARMEL

Employee

Twitter

Next Earnings Date

2026-08-06

Latest SEC Filings

MBX's Discussions on Twitter

Compare MBX vs VRTX, REGN, ARGX, MRNA, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
MBX Mbx Biosciences Inc	61.72	3.20B	0	-86.97M	-81.88M	-2.4189
VRTX Vertex Pharmaceuticals Inc	546.12	136.93B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	827.72	85.11B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	1,033.15	64.95B	4.16B	1.29B	734.26M	19.58
MRNA Moderna Inc	145.55	53.23B	2.23B	-3.19B	-1.60B	-8.1462
RVMD Revolution Medicines Inc	210.02	45.38B	742.00K	-1.37B	-1.07B	-7.0731

Mbx Biosciences Inc Stock (MBX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-28-26	Initiated	Barclays	Overweight
Dec-04-25	Initiated	Goldman	Sell
Nov-04-25	Initiated	TD Cowen	Buy
Oct-15-25	Initiated	Truist	Buy
Aug-15-25	Resumed	Jefferies	Buy
Aug-05-25	Initiated	Mizuho	Outperform
Jul-16-25	Initiated	Oppenheimer	Outperform
Apr-10-25	Initiated	Citizens JMP	Mkt Outperform
Oct-08-24	Initiated	Guggenheim	Buy
Oct-08-24	Initiated	JP Morgan	Overweight
Oct-08-24	Initiated	Jefferies	Buy
Oct-08-24	Initiated	Stifel	Buy

View All

Mbx Biosciences Inc Stock (MBX) Latest News

Aug 21, 2026

MBX BIOSCIENCES, INC. : JP MORGAN RESUMES COVERAGE WITH OVERWEIGHT RATING; TARGET PRICE $88 - Bitget

Aug 21, 2026

JPMorgan Chase & Co. Initiates Coverage on MBX Biosciences (NASDAQ:MBX) - MarketBeat

Aug 21, 2026

Aug 20, 2026

Deep Track Capital Reduces MBX Biosciences Stake in Strategic Pr - GuruFocus

Aug 20, 2026

MBX (MBX) Move: Finishes 2.76% Lower at $66.51 on the Day; Technical View: the Supplied Trading Band Runs From $63.18 to $69.84 on the DayMean Reversion Trade - Vinanet

Aug 20, 2026

Aug 19, 2026

MBX (MBX) Snapshot: Finishes 0.13% Lower at $66.44 on the Day; Boundary Watch: $63.12 and $69.76 Define the Nearby Reference Levels for the Current SessionBollinger Squeeze - Vinanet

Aug 19, 2026

Aug 17, 2026

MBX Biosciences (NASDAQ: MBX) insider to sell 3,745 shares - Stock Titan

Aug 17, 2026

MBX Biosciences (MBX) Edges Lower to $68.12, Consolidating Between Support and ResistanceZigzag Correction - vinanet.vn

Aug 17, 2026

Aug 16, 2026